Skip to main content

Advertisement

Table 2 Baseline patient characteristics

From: Bloodstream infections at a tertiary level paediatric hospital in South Africa

  CA-BSI
(N = 248a)
HA-BSI
(N = 371a)
HCA-BSI
(N = 74)
Total BSIs
(N = 693a)
Age median (IQR) 9.3 (3.1–39.3) 13.0 (4.0–59.7) 7.1 (1.4–67.0) 11.5 (3.6–50.0)
Age categories, n/N(%)
 0–28 days 31 (12.5) 28 (7.5) 16 (21.6) 75 (10.8)
 1 - < 2 months 17 (6.9) 17 (4.6) 6 (8.1) 40 (5.8)
 2 - < 12 months 88 (35.5) 132 (35.6) 22 (29.7) 242 (34.9)
 12 months – < 5 years 67 (27) 106 (28.6) 11 (14.9) 184 (26.5)
  > 5 years 45 (18.1) 88 (23.7) 19 (25.7) 152 (21.9)
 WAZ median (IQR) −1.2 (−2.5–0.1) −1.8 (−3.4–0.6) −1.9 (−3.3–1.0) −1.6 (−3–0.3)
WAZ categories, n/N (%)
 Severe underweight 44/240 (18.3) 103/361 (28.5) 22/69 (31.9) 169/670 (25.2)
 Moderate underweight 33/240 (13.8) 60/361 (16.6) 11/69 (15.9) 104/670 (15.5)
 Mild-normal 163,240 (67.9) 198/361 (54.8) 36/69 (52.2) 397/670 (59.3)
 HIV-infected, n/N (%) 33 (13.3) 33 (8.9) 4 (5.4) 70 (10.1)
 HIV-uninfected, n/N (%) 172 (69.3) 232 (62.5) 49 (66.2) 454 (65.5)
 HIV not tested, n/N (%) 43 (6.2) 106 (28.6) 21 (28.4) 169 (24.4)
 Receiving ART at the time of the BSI in HIV infected child, n/N(%) 11/33 (33.3) 29/33 (87.9) 3/4 (75) 43/70 (61.4)
  1. a N denominator used unless otherwise stated, IQR interquartertile range, BSI bloodstream infection, CA-BSI community-acquired bloodstream infection, HA-BSI hospital-acquired bloodstream infection, HCA-BSI healthcare-associated bloodstream infection, WAZ weight-for-age z-score, HIV-infected human immunodeficiency virus infected, ART antiretroviral therapy